To elucidate the association between stressful life events and the development of cancer the influence of life stress on relapse in operable breast cancer was examined in matched pairs of women in a casecontrol study. Adverse life events and difficulties occurring during the postoperative disease free interval were recorded in 50 women who had developed their first recurrence of operable breast cancer and during equivalent follow up times in 50 women with operable breast cancer in remission. The cases and controls were matched for the main physical and pathological factors known to be prognostic in breast cancer and sociodemographic variables that influence the frequency of life events and difficulties. Severely threatening life events and difficulties were significantly associated with the first recurrence of breast cancer. The relative risk of relapse associated with severe life events was 5-67 (95% confidence interval 1-57 to 37.20), ard the relative risk associated with severe difficulties was 4*75 (1.58 to 19.20). Life events and difficulties not rated as severe were not related to relapse. Experiencing a non-severe life event was associated with a relative risk of 2-0 (0.62 to 7.47), and experiencing a non-severe difficulty was associated with a relative risk of 1-13 (0-38 to 3-35).
Introduction
The association between stressful life events and the development of cancer is supported bv a large body of anecdotal clinical evidence that has been collected since the eighteenth century. Recent, more substantive clinical and epidemiological evidence for a link between life events and the onset of cancer has been less consistent and flawed by conceptual and methodological weaknesses. The most important of these shortcomings has been the inability to date accurately the onset of tumour growth. This is a necessary prerequisite for anv study claiming to investigate the influence of stress on that onset. Moreover, unreliable measures of stressful experiences have been used and control groups have been poorly chosen.
The role of life events in the prognosis of cancer has received much less attention but is more easily studied bccause progression of the disease is more amenable to measurement. Early and accurate diagnosis of relapse is facilitated by the regular follow up of patients with cancer in oncology units. Using a measure of life events that overcomcs many of the problems of low reliability and validity that have undermined research on life stress,' we examined the influence of adverse life experiences on the development of relapse in women with operable breast cancer.
Patients and methods
Data on life events were collected from 50 consecutive women who had developed a first recurrence after treatment of operable breast cancer. Recurrences (local or distant) were diagnosed according to the criteria of Havward et al. 4 Similar data were obtained from a control group of women whose operable breast cancer was in remission according to clinical and investigatory criteria.
The matching of the women who had a relapse with their controls was performed by computer searches of the database at the clinical oncology unit, Guy's Hospital, which contains clinical, pathological, and demographic information on all women with breast cancer who have attended the unit. The cases and controls were matched in pairs for the main physical and pathological factors known to be prognostic in breast cancer. These included type of operation, whether or not the patient had received adjuvant chemotherapy, menopausal state, affected lymph nodes, tumour size, and histological type of tumour. The cases and controls were then also matched for date of operation and those sociodemographic variables that influence the frequency of life events in the general population.
For the women whose breast cancer relapsed the life events data were collected for the period between the date of operation and the date of recurrence. The life events data for the controls were ascertained over the equivalent follow up period from the date of their operation. Adverse life experiences were measured with the Bedford College life events and difficulties schedule,' an instrument based on an interview that assesses not only discrete life events but also more persistent, continuing difficulties. Only those adverse life events and difficulties (stressors) that met strictly predefined criteria were considered for inclusion. The severity of stressors was rated by a panel of judges according to their undesirability and threat to the subject. Ratings were based on how a hypothetical woman would be expected to react, given the details of the events, the circumstances surrounding them, and the woman's biography. The pairs were well matched for the treatments they received, with only minor mismatches for menopausal state, number of affected axillary lymph nodes, tumour size, and histological type of tumour. There were no major mismatches for age, marital state, social class, and life stage (an index reflecting age and the presence of children in the subject's household). Table  I gives an overall comparison of the prognostic factors in the cases and controls. Table II shows the numbers of pairs of women who experienced at least one adverse stressor during the disease free interval or the equivalent follow up time. In 10 pairs only the woman who had a relapse had experienced any adverse life event and in four pairs only the control had. Hence the relative risk for relapse associated with an adverse life event of any severity was 2-5 (p=0 2). Experience of non-severe life events was associated with a lower relative risk of 2 00 (p=0 3). In 17 pairs the woman who had a relapse had experienced a severe life event and her control had not, and in three pairs the control had experienced a severe life event and the woman who had a relapse had not. Thus, a significant relative risk (5 67) was associated with the experience of a severe life event (p = 0 004).
The relative risk of relapse associated with the experience of difficulties followed a similar pattern. For difficulties of any severity the relative risk was 2 -80 (p=0 7) and for non-severe difficulties 1 13 (p=l 0), whereas experience of severe difficulties was associated with a significant relative risk of 4 75 (p=0004). Experiencing either a severe life event or a severe difficulty was associated with an even greater relative risk (9-00): there were nine times as many pairs in which only the woman who had a relapse had experienced a severe stressor of either type as there were pairs in which only the control had (p<0 001).
Discussion
The findings of this study suggest a prognostic association between severe life stressors and recurrence of operable breast cancer. Whether overall survival from breast cancer is altered by severe stress has yet to be determined. Results of recent studies using cancer mortality statistics provide some support for the link between adverse life events and survival with cancer. Based on data from the Office of Population Censuses and Surveys a weak association was found between death ofa wife and subsequent death from cancer of the widower after a long latent interval,7 but further follow up of the cohort of widowers is required before final conclusions can be drawn. Also, decreased survival with breast cancer was shown in women aged over 60 who had experienced death, illness, or unemployment in members of their household in the five years before their malignant disease was diagnosed.8
The design of our study overcame many of the BMJ VOLUME 298 4 FEBRUARY 1989 objections to the previous research that looked at stress and the development of cancer. In particular, we rigorously controlled for the main physical and pathological factors that are known to influence prognosis in breast cancer. A measure of life stressors was used that accurately dated events and difficulties to ensure that they preceded the clinical onset of progression of the disease. This measure also attempted to assess the objective threat of life events and difficulties independently of both the subject's emotional reaction and investigator bias. This is important as neither the patient nor the investigator could be blinded to the woman's disease state. Unconsciously motivated differences in the subject's recall and interviewer's techniques remain a possible source of bias. If these were operating, however, a more systematic excess of both non-severe and severe stressors among the women with a relapse would be expected. The small numbers of women who participated in this study must be borne in mind when interpreting the results, a factor that is reflected in the wide confidence intervals associated with the estimates of relative risk. The findings of this study now need to be corroborated in a large prospective investigation.
The mechanism whereby stress might affect the relapse of breast cancer is unknown. Suggested intermediaries include the neuroendocrine9 and immune systems,' " which could promote growth of previously dormant or subclinical metastases. Investigations of this are complex and difficult. [12] [13] [14] 
